Cargando…
Value of a cure for sickle cell disease in reducing economic disparities
Autores principales: | Graf, Marlon, Tuly, Rifat, Gallagher, Meghan, Sullivan, Jeff, Jena, Anupam Bapu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544336/ https://www.ncbi.nlm.nih.gov/pubmed/35604241 http://dx.doi.org/10.1002/ajh.26617 |
Ejemplares similares
-
Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel
por: Graf, Marlon, et al.
Publicado: (2021) -
A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors
por: Veeranki, Sreenivas P, et al.
Publicado: (2021) -
Economic Value of Medical Institutions
por: Jamal-Ud-Din,
Publicado: (1931) -
Is Hib Vaccine of Economic Value in South Korea?
por: Griffiths, Ulla K., et al.
Publicado: (2009) -
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
por: Jena, Anuraag, et al.
Publicado: (2021)